Crossref journal-article
American Physiological Society
American Journal of Physiology-Lung Cellular and Molecular Physiology (24)
Abstract

The lung collectin surfactant protein A (SP-A) has both anti-inflammatory and prophagocytic activities. We and others previously showed that SP-A inhibits the macrophage production of tumor necrosis factor (TNF)-α stimulated by the gram-negative bacterial component LPS. We propose that SP-A decreases the production of proinflammatory cytokines by alveolar macrophages via a CD14-independent mechanism. SP-A inhibited LPS-simulated TNF-α production in rat and mouse macrophages in the presence and absence of serum (72% and 42% inhibition, respectively). In addition, SP-A inhibited LPS-induced mRNA levels for TNF-α, IL-1α, and IL-1β as well as NF-κB DNA binding activity. SP-A also diminished ultrapure LPS-stimulated TNF-α produced by wild-type and CD14-null mouse alveolar macrophages by 58% and 88%, respectively. Additionally, SP-A inhibited TNF-α stimulated by PMA in both wild-type and TLR4-mutant macrophages. These data suggest that SP-A inhibits inflammatory cytokine production in a CD14-independent manner and also by mechanisms independent of the LPS signaling pathway.

Bibliography

Alcorn, J. F., & Wright, J. R. (2004). Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. American Journal of Physiology-Lung Cellular and Molecular Physiology, 286(1), L129–L136.

Authors 2
  1. John F. Alcorn (first)
  2. Jo Rae Wright (additional)
References 46 Referenced 47
  1. 10.1126/science.3754653
  2. 10.1097/00005344-199500252-00002
  3. 10.1152/ajplung.2000.278.4.L840
  4. 10.1165/ajrcmb.18.3.2972
  5. 10.1074/jbc.M009164200
  6. 10.1073/pnas.92.11.4848
  7. 10.4049/jimmunol.168.12.5989
  8. 10.1084/jem.182.1.147
  9. 10.1073/pnas.96.9.4953
  10. 10.1152/ajplung.1997.272.2.L344
  11. 10.1016/S0952-7915(99)80003-X
  12. 10.1152/ajplung.1994.267.6.L712
  13. 10.4049/jimmunol.168.8.4012
  14. 10.1172/JCI5849
  15. 10.1165/ajrcmb.19.4.3254
  16. 10.1165/ajrcmb.20.2.3303
  17. 10.4049/jimmunol.165.7.3934
  18. 10.1177/096805199400100202
  19. 10.1016/0014-4827(91)90081-5
  20. Mariencheck WI, Savov J, Dong Q, Tino MJ, and Wright JR.Surfactant protein-A enhances alveolar macrophage phagocytosis of a live, mucoid strain ofP. aeruginosa.Am J Physiol Lung Cell Mol Physiol277: L777-L786, 1999. (10.1152/ajplung.1999.277.4.L777)
  21. 10.1152/ajplung.1996.271.2.L310
  22. Monick MM, Carter AB, Gudmundsson G, Mallampalli R, Powers LS, and Hunninghake GW.A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinase in lipopolysaccharide-stimulated human alveolar macrophages.J Immunol162: 3005-3012, 1999. (10.4049/jimmunol.162.5.3005)
  23. 10.4049/jimmunol.165.8.4272
  24. 10.1074/jbc.M106671200
  25. 10.1002/jlb.56.1.27
  26. 10.1002/jemt.1070260505
  27. Ohmer-Schrock D, Schlatterer C, Plattner H, and Schlepper-Schafer J.Lung surfactant protein A activates a phosphoinositide/calcium signaling pathway in alveolar macrophages.J Cell Sci108: 3695-3702, 1995. (10.1242/jcs.108.12.3695)
  28. 10.1093/infdis/172.2.481
  29. 10.1006/bcmd.1998.0201
  30. Rosseau S, Hammerl P, Maus U, Gunther A, Seeger W, Grimminger F, and Lohmeyer J.Surfactant protein A down-regulates proinflammatory cytokine production evoked byCandida albicansin human alveolar macrophages and monocytes.J Immunol163: 4495-4502, 1999. (10.4049/jimmunol.163.8.4495)
  31. Sano H, Sohma H, Muta T, Nomura SI, Voelker DR, and Kuroki Y.Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.J Immunol163: 387-395, 1999. (10.4049/jimmunol.163.1.387)
  32. Schagat T, Tino MJ, and Wright JR.Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A.Infect Immun67: 4693-4699, 1999. (10.1128/IAI.67.9.4693-4699.1999)
  33. 10.1165/rcmb.4812
  34. 10.1165/ajrcmb.23.6.4083
  35. 10.1152/ajplung.1999.276.3.L540
  36. 10.1002/jlb.61.6.736
  37. 10.1016/S0952-7915(99)80004-1
  38. Van Der Bruggen T, Njenhuis S, Van Raaij E, Verhoef J, and Van Asbeck BS.Lipopolysaccharide-induced tumor necrosis factor α production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway.Infect Immun67: 3824-3829, 1999. (10.1128/IAI.67.8.3824-3829.1999)
  39. 10.1042/bj3030407
  40. 10.1165/ajrcmb/2.1.91
  41. Viriyakosol S, Tobias PS, Kitchens RL, and Kirkland TN.MD-2 binds to bacterial lipopolysaccharide.J Biol Chem276: 38044-38051, 2001. (10.1074/jbc.M105228200)
  42. 10.1152/ajplung.2000.278.5.L946
  43. 10.1016/S0039-6060(97)90010-6
  44. 10.1152/physrev.1997.77.4.931
  45. Wright JR, Wagner RE, Hawgood S, Dobbs LG, and Clements JA.Surfactant apoprotein Mr = 26000-36000 enhances uptake of liposomes by type II cells.J Biol Chem262: 2888-2894, 1987. (10.1016/S0021-9258(18)61590-X)
  46. 10.1152/ajplung.1999.276.4.L650
Dates
Type When
Created 21 years, 6 months ago (Jan. 30, 2004, 7:55 p.m.)
Deposited 2 years, 3 months ago (April 27, 2023, 4:21 p.m.)
Indexed 4 months, 3 weeks ago (March 30, 2025, 6:23 p.m.)
Issued 21 years, 7 months ago (Jan. 1, 2004)
Published 21 years, 7 months ago (Jan. 1, 2004)
Published Print 21 years, 7 months ago (Jan. 1, 2004)
Funders 0

None

@article{Alcorn_2004, title={Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway}, volume={286}, ISSN={1522-1504}, url={http://dx.doi.org/10.1152/ajplung.00427.2002}, DOI={10.1152/ajplung.00427.2002}, number={1}, journal={American Journal of Physiology-Lung Cellular and Molecular Physiology}, publisher={American Physiological Society}, author={Alcorn, John F. and Wright, Jo Rae}, year={2004}, month=jan, pages={L129–L136} }